US 6951917
MHC-class II restricted melanoma antigens and their use in therapeutic methods
expired A61KA61K38/00
Quick answer
US patent 6951917 (MHC-class II restricted melanoma antigens and their use in therapeutic methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 61
- CPC classes
- A61K, A61K38/00